BCI
WVE icon

Brinker Capital Investments’s Wave Life Sciences WVE Stock Holding History

Brinker Capital Investments’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$166K Sell
22,846
-2,184
-9% -$28.5K ﹤0.01% 1887
2025
Q4 		$426K Sell
25,030
-385
-2% -$3.91K ﹤0.01% 1658
2025
Q3 		$186K Buy
25,415
+1,023
+4% +$8.28K ﹤0.01% 1981
2025
Q2 		$159K Buy
24,392
+5,182
+27% +$34.2K ﹤0.01% 1922
2025
Q1 		$155K Buy
19,210
+3,419
+22% +$37.4K ﹤0.01% 1831
2024
Q4 		$195K Buy
15,791
+850
+6% +$11.3K ﹤0.01% 1756
2024
Q3 		$123K Buy
+14,941
New +$89.3K ﹤0.01% 1741

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return